ADC Therapeutics Director Azelby Sells Shares Amid Price Target Cut by Mark Eisenberg 20.06.2024 Robert Azelby sells $20,215 in ADC Therapeutics shares for tax reasons; holds 53,005 shares. Investors eye insider actions for future ...